ProPhase Labs, Inc., a biopharma, genomics, and diagnostics Company, announced an innovative step forward in cancer treatment research with the introduction of Project ZenQ-AI. This project employs the Company’s state-of-the-art AI platform which was meticulously developed with leading AI technology platforms and systems. The Company is harnessing its extensive...
TetraScience, the Scientific Data and AI Cloud company, announced a strategic partnership with Google Cloud at the Bio-IT World Conference & Expo to speed up drug development and other scientific discoveries. By bringing the Tetra Scientific Data and AI Cloud together with Google Cloud’s infrastructure and AI technologies, the...
Ezra, AI Leader in the Full Body MRI Space, Announces Partnership with RAYUS Radiology
AIT365 News Desk -
Ezra, the healthcare AI startup transforming early cancer detection through full body MRI screening, announced a partnership with RAYUS Radiology, a leading provider of imaging services. The partnership will enable Ezra to expand nationally in 150 RAYUS locations across the U.S.
Ezra utilizes medical imaging and Artificial Intelligence to monitor...
Expert.ai, the industry leader in providing AI-powered language solutions to enterprises, announced the launch of the expert.ai Insight Engine for Life Sciences.
For the world of drug research and development, data is both a challenge to be managed and an opportunity to be leveraged. The ability to effectively and quickly...
New England Biolabs® launches Monarch Mag Viral DNA/RNA Extraction Kit to enable highly sensitive viral detection
AIT365 News Desk -
New England Biolabs announces the release of its Monarch Mag Viral DNA/RNA Extraction Kit. This extraction kit enhances recovery of low amounts of viral nucleic acid to enable highly sensitive detection. The kit uses a magnetic bead-based process to extract viral RNA and DNA reproducibly and efficiently, while enabling...
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer’s disease diagnosis
AIT365 News Desk -
Roche announced that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). This blood test, which is being developed in collaboration with Eli Lilly and Company, will be used to help identify the presence or absence of amyloid pathology in individuals, which...
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
AIT365 News Desk -
Charles River Laboratories International, Inc. announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI) decision support tool developed in collaboration with Deciphex, an innovator in pathology AI. By combining Deciphex’s unique digital pathology solutions with Charles River’s robust non-clinical pathology programs, clients of both organizations will have...
Prenosis Announces Commercial Distribution Collaboration With Roche For Sepsis Immunoscore™, The First FDA De Novo Authorized Artificial Intelligence Tool For Sepsis Detection
AIT365 News Desk -
Prenosis will collaborate with Roche to bring the Sepsis ImmunoScore™ to hospitals across the United States on Roche's navify® Algorithm Suite platform
Prenosis, Inc., an artificial intelligence company enabling precision medicine in acute care, announced a commercial distribution collaboration with Roche for its Sepsis ImmunoScore™, an artificial intelligence/machine learning software as a medical device (AI...
PredxBio and PictorLabs Forge Strategic Partnership to Advance Cancer Research and Diagnostics with Next Generation Spatial Analytics
AIT365 News Desk -
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital pathology firm pioneering AI-powered virtual staining technology, are pleased to announce a transformative partnership aimed at revolutionizing cancer research, diagnosis, and treatment.
PredxBio, Inc., a leader in spatially intelligent biology, and PictorLabs, Inc., a leading digital...
InfoBionic Rebrands Company Name to ‘InfoBionic.Ai’, Reinforcing Focus on AI-Enabled ECG
AIT365 News Desk -
InfoBionic.Ai continues to advance its mission of improving outcomes and enabling better cardiac care with a name that captures the essence of its next gen, AI-enabled virtual telemetry solution.
InfoBionic.Ai, a digital health company providing AI-powered diagnostic remote patient monitoring solutions, announced that it has evolved its company name from...